Melita Sun Jung, Chief Business Officer at Terns Pharmaceuticals, Inc. (TERN), bought 2,250 shares at $5.11 ($11K) on 2024-11-30, disclosed to the SEC on 2025-02-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.